[Importance of regional circulation for treatment of cardiogenic shock].
D000804:Angiotensin II / Q000627:therapeutic use; D000818:Animals; D001145:Arrhythmias, Cardiac; D001158:Arteries; D001794:Blood Pressure; D002302:Cardiac Output; D004285:Dogs; D004837:Epinephrine / Q000627:therapeutic use; D006339:Heart Rate; D006439:Hemodynamics; D006801:Humans; D007773:Lactates / Q000097:blood; D009921:Metaproterenol / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy; D010101:Oxygen Consumption; D011773:Pyruvates / Q000097:blood; D012039:Regional Blood Flow; D012769:Shock / Q000188:drug therapy / Q000209:etiology*; D014655:Vascular Resistance; D014680:Veins
D007773:Lactates; D011773:Pyruvates; D000804:Angiotensin II; D009921:Metaproterenol; D004837:Epinephrine
Zur Bedeutung von Teikreisläufen für die Behandlung des cardiogenen Schocks.